Protective T-cell-based immunity induced in neonatal mice by a single replicative cycle of herpes simplex virus
about
Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknownRecombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice.Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newbornRecent progress in herpes simplex virus immunobiology and vaccine researchInduction of CD8 T cell heterologous protection by a single dose of single-cycle infectious influenza virus.Safety and immunogenicity in neonatal mice of a hyperattenuated Listeria vaccine directed against human immunodeficiency virusMaternal vaccination: moving the science forward.Cytomegalovirus upregulates expression of CCR5 in central memory cord blood mononuclear cells, which may facilitate in utero HIV type 1 transmission.IL-12p40/IL-10 Producing preCD8α/Clec9A+ Dendritic Cells Are Induced in Neonates upon Listeria monocytogenes InfectionFuture of an "Asymptomatic" T-cell Epitope-Based Therapeutic Herpes Simplex VaccineImmunization of pregnant women: Future of early infant protection.Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers.An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs.Prophylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virusInterplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1.Induction of protective immunity to Listeria monocytogenes in neonates.Safety and efficacy of neonatal vaccination.Phenotype and function of neonatal DC.Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways.Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs.Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges.Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication.Pulmonary Dendritic Cell Subsets Shape the Respiratory Syncytial Virus-Specific CD8+ T Cell Immunodominance Hierarchy in Neonates.Long-lasting protective antiviral immunity induced by passive immunotherapies requires both neutralizing and effector functions of the administered monoclonal antibody.Flt3 ligand-treated neonatal mice have increased innate immunity against intracellular pathogens and efficiently control virus infections.
P2860
Q21296712-CC783EE6-92F2-4196-A2C7-419B518A5CFEQ33584559-FEBA52AE-3370-47F9-8086-D52CE6E8C36DQ33835386-3F406398-19B6-4C8F-BB1A-8DE3FE4D8178Q33963713-1521F251-EA36-48B4-ADAE-682546D9E061Q34261441-EC54083A-88EB-41F5-98D2-4E8C15900ACEQ34357413-ECD74492-3515-48A7-98EC-ED5B1AAE4665Q34630952-4590580A-20AF-4F28-BB33-BD6D54B48941Q35127311-1B49B389-6FFA-4E09-B917-A6E073EB0AC2Q35988496-15BD93B5-40B1-407B-A652-CEE4ED3FAF0EQ36025675-DAFE5370-8958-4BDD-9EF2-37CFCB03CF3BQ36389045-85C9E9FD-7E90-4E1E-BCE7-08A70FC9A227Q36444097-5F76CDE4-78A3-4DBA-906A-10DD99C9B4E4Q36759693-3D3841B0-8B11-46EC-A462-93C66AB25FB2Q36879345-5A25F155-C113-4D40-8682-E30C703BC5E2Q37093565-0B4DE296-908E-41E5-B38B-F24CE6BE38B8Q37252100-3E1D9AA6-7673-4743-972F-DF00E5B4672EQ37336304-56C40F95-CCE0-469F-ABC6-D0F7F0A0D5C0Q37366648-9CAC6817-9646-4888-A41B-0A0C9AA6E7CDQ37388802-C30B60F5-64D4-49A8-AB44-E83239DA4043Q37746861-3D5A69A3-DB41-47C0-9354-89617A77BFFDQ38269845-958E3B80-BCFC-4E25-8EB2-40EA52E2A6DDQ39604323-DC87B1B2-E099-48F9-A210-5356329F66D4Q39683981-DAEB7ED2-3BD1-4474-9346-DDA0663C4142Q40432390-7D33B760-4C9A-42B3-B295-24FC11FD715BQ41857868-F1975678-0CE7-45C1-859E-81CD613E8AF1Q41963648-678082EC-D4EE-4E8D-B095-1CC44F16CF9A
P2860
Protective T-cell-based immunity induced in neonatal mice by a single replicative cycle of herpes simplex virus
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Protective T-cell-based immuni ...... cycle of herpes simplex virus
@ast
Protective T-cell-based immuni ...... cycle of herpes simplex virus
@en
type
label
Protective T-cell-based immuni ...... cycle of herpes simplex virus
@ast
Protective T-cell-based immuni ...... cycle of herpes simplex virus
@en
prefLabel
Protective T-cell-based immuni ...... cycle of herpes simplex virus
@ast
Protective T-cell-based immuni ...... cycle of herpes simplex virus
@en
P2093
P2860
P1433
P1476
Protective T-cell-based immuni ...... cycle of herpes simplex virus
@en
P2093
P2860
P356
10.1128/JVI.75.1.83-89.2001
P577
2001-01-01T00:00:00Z